MedPath

Optimal Bowel Preparation Regimen in Patients With Colorectal Surgery

Phase 4
Conditions
Bowel Preparation
Interventions
Drug: standard preparation (2L PEG-ELS)
Drug: low-volume preparation (10 mg bisacodyl plus 2L PEG-ELS)
Drug: high-volume preparation (4L PEG-ELS)
Registration Number
NCT02761317
Lead Sponsor
Shandong University
Brief Summary

The study compares the efficacy of bowel cleansing between the standard preparation (2 L polyethylene glycol electrolyte solution, 2 L PEG-ELS), low-volume preparation (10 mg bisacodyl plus 2 L PEG-ELS) and high-volume preparation (4 L PEG-ELS) in patients with previous colorectal resection.

Detailed Description

Colonoscopy is the standard approach for evaluating the colon currently. Thorough bowel cleansing is critical for adequate visualization of colonic mucosa during colonoscopy. Inadequate bowel cleansing results in adverse consequences for the examination, including lower adenoma detection rates, longer procedural time, lower cecal intubation rates, shorter intervals between examinations and an estimated 12-22% increase in overall colonoscopy cost. A history of colorectal resection represents an independent predictor for inadequate colon cleansing,hence strategies to improve bowel preparation may be a demanding goal in this subset of patients.

The study compares the efficacy of bowel cleansing between the standard preparation (2 L polyethylene glycol electrolyte solution, 2 L PEG-ELS), low-volume preparation (10 mg bisacodyl plus 2 L polyethylene glycol electrolyte solution) and high-volume preparation (4L polyethylene glycol electrolyte solution, 4L PEG-ELS) in patients with previous colorectal resection. Then the investigators can select the optimized regimen for patients with colorectal surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • All adults (18< age<75years) referred for surveillance colonoscopy with a history of colorectal resection for Colorectal cancer (CRC).
Exclusion Criteria
  • severe comorbidities (e.g. congestive heart failure and severe kidney disease)
  • abdominal and pelvic surgery other than colorectal resection for the cause of CRC.
  • severe colonic stricture or obstructing tumour
  • dysphagia
  • compromised swallowing reflex or mental status
  • significant gastroparesis or gastric outlet obstruction
  • known or suspected bowel obstruction or perforation
  • severe chronic renal failure (creatinine clearance<30 ml/min
  • severe congestive heart failure (New York Heart Association class III or IV)
  • uncontrolled hypertension (systolic blood pressure>170 mm Hg, diastolic blood pressure>100 mm Hg)
  • inflammatory bowel disease or megacolon
  • dehydration
  • disturbance of electrolytes
  • pregnancy or lactation
  • haemodynamically unstable
  • unable to give informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GroupA:standard preparationstandard preparation (2L PEG-ELS)Subjects who are randomized into group A receive standard bowel preparation (2L PEG-ELS) on the same-day of procedure.
Group B:low-volume preparationlow-volume preparation (10 mg bisacodyl plus 2L PEG-ELS)Subjects who are randomized into group B receive 10mg bisacodyl at 6 pm on the evening before the colonoscopy and 2L PEG-ELS on the same-day of procedure. ( 2L PEG-ELS and 10mg bisacodyl )
Group C:high-volume preparationhigh-volume preparation (4L PEG-ELS)Subjects who are randomized into group C will receive 2L PEG-ELS at 6 pm before the procedure and another 2L PEG-ELS on the same-day of procedure. (4 L PEG-ELS)
Primary Outcome Measures
NameTimeMethod
Difference of scores rating by Aronchick Preparation Scale among 3 groups.6 months

This is an established rating scale to evaluate the quality of bowel prep. The ratings will be compared among the 3 groups.

Secondary Outcome Measures
NameTimeMethod
Rate of compliance with instructions among 3 groups6 months

Compliance was scored on a 3-grade scale based on the intake of bowel solution: 0 = optimal (intake of 100% of the solution); 1 = good (intake of ≥75% of the solution); 2 = poor (intake of \<75% of the solution).

Withdrawal time among 3 groups.6 months

Withdrawal time from ileocecum, not including the time of treatment and biopsy for polyps.

Caecal intubation rate among 3 groups.6 months

Caecal intubation rate is defined the proportion of patients with caecal intubation.

Willingness to repeat bowel preparation among 3 groups.6 months

the willingness to repeat the same bowel preparation,a patient's subjective evaluation of the bowel preparation was recorded by a questionnaire

Polyp detection rate among 3 groups.6 months

Polyp detection rate was defined as the proportion of patients with at least one polyp.

Trial Locations

Locations (1)

Department of Gastroenterology, Qilu Hospital, Shandong University

🇨🇳

Jinan, Shandong, China

Department of Gastroenterology, Qilu Hospital, Shandong University
🇨🇳Jinan, Shandong, China
Yanqing Li, PhD. MD.
Contact
86-531-82169236
qiluliyanqing@gmail.com
Yanqing li, PhD. MD.
Principal Investigator
© Copyright 2025. All Rights Reserved by MedPath